Answer to Question 1
A
Feedback:
Monoclonal antibodies should be used cautiously in patients who have had previous administration of the monoclonal antibody (serious hypersensitivity reactions can occur with repeat administration). The nursing priority would be to question the order because the patient has already received alemtuzumab (Compath) previously and if the order is verified, this patient should be monitored very carefully, perhaps starting to infuse more slowly until the patient's reaction can be determined. Only after questioning the order and having it verified would the nurse perform hand hygiene and begin the infusion.
Answer to Question 2
D
Feedback:
Cholestyramine should be mixed with water or other noncarbonated fluids so the nurse now recognizes the need for medication teaching and chooses the nursing diagnosis related to deficient knowledge. Nothing in this question indicates that the patient is experiencing any adverse effects from the drug so that pain and constipation would not be optimal nursing diagnoses. Until the nurse assesses the patient's understanding of how to take the drug, it would be incorrect to assume noncompliance when it may actually be lack of understanding.
Measuring Patient Height
Patient teaching: mouth and pharyngeal assessment
It is important to act concerned when a patient is upset.
How is this worker trying to avoid becoming a depersonalized unit in a bureaucratic-economic ...
A histologic slide showing the sponge-like architecture of a patient with Creutzfeldt-Jakob Disease.